Osimertinib 40 mg tablet |
Company |
Formulation ID |
FDA Description |
AstraZeneca
|
F16071
|
Sodium stearyl fumarate; Mannitol; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Polyethylene glycol 3350; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose, low substituted |
------------------------------------------------------------------------------------ |
|
|
|
Osimertinib 80 mg tablet |
Company |
Formulation ID |
FDA Description |
AstraZeneca
|
F16072
|
Sodium stearyl fumarate; Mannitol; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Talc; Titanium dioxide; Polyethylene glycol 3350; Polyvinyl alcohol; Cellulose, microcrystalline; Hydroxypropyl cellulose, low substituted |
------------------------------------------------------------------------------------ |
|
|
|
Osimertinib Mesylate eq 40mg base tablet |
Company |
Formulation ID |
FDA Description |
Astrazeneca
|
F23977
|
Mannitol; Microcrystalline Cellulose; Low-Substituted Hydroxypropyl Cellulose; Sodium Stearyl Fumarate; Polyvinyl Alcohol; Titanium Dioxide; Macrogol 3350; Talc; Ferric Oxide Yellow; Ferric Oxide Red; Ferric Oxide Black |
------------------------------------------------------------------------------------ |
|
|
|
Osimertinib Mesylate eq 80mg base tablet |
Company |
Formulation ID |
FDA Description |
Astrazeneca
|
F23978
|
Mannitol; Microcrystalline Cellulose; Low-Substituted Hydroxypropyl Cellulose; Sodium Stearyl Fumarate; Polyvinyl Alcohol; Titanium Dioxide; Macrogol 3350; Talc; Ferric Oxide Yellow; Ferric Oxide Red; Ferric Oxide Black |
------------------------------------------------------------------------------------ |
|
|
|